Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.70 +0.32 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Property, Plant & Equipment (Net) (2013 - 2026)

Atara Biotherapeutics (ATRA) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Atara Biotherapeutics 141.08 Mn 124.53 Mn 439,000.00 41,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 41,000.00
Jun 30, 2026 41,000.00
Mar 31, 2026 55,000.00
Mar 31, 2026 55,000.00
Dec 31, 2025 73,000.00
Dec 31, 2025 73,000.00
Sep 30, 2025 147,000.00
Sep 30, 2025 147,000.00
Jun 30, 2025 176,000.00
Jun 30, 2025 176,000.00
Mar 31, 2025 285,000.00
Mar 31, 2025 285,000.00
Dec 31, 2024 1.29 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 1.66 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 2.32 Mn
Jun 30, 2024 2.32 Mn
Mar 31, 2024 2.99 Mn
Mar 31, 2024 2.99 Mn